Benchmarking study shows streamlined structural variant detection and high concordance for ogm compared to chromosomal microarray analysis, the global standard in genetic disease analysis

San diego, sept. 28, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced the publication of the first peer-reviewed benchmarking study to compare optical genome mapping (ogm) to the current global standard in molecular analysis of constitutional genetic disorders, chromosomal microarray analysis (cma).
BNGO Ratings Summary
BNGO Quant Ranking